News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Three New Oncology Practices Sign Agreements with Cardinal Health Specialty Solutions' VitalSource Group Purchasing Organization
06/25/2012

DUBLIN, Ohio -- June 25, 2012 -- Cardinal Health Specialty Solutions today announced that three new community oncology practices – Birmingham Hematology and Oncology Associates (BHOA) in Birmingham, Ala.; Michigan Healthcare Professionals, P.C. in Michigan; and California Cancer Associates for Research and Excellence (cCARE) in Fresno, Calif. – have selected VitalSourceTM GPO as their group purchasing organization for infused oncology and other specialty medications.

 

Through these new agreements, VitalSource GPO will provide these three large oncology groups with competitive pricing, rebates and access to reliable, on-time delivery for life-saving chemotherapy, biologic and supportive care medications. 

 

For more than 25 years, BHOA’s team of 16 board-certified physicians has provided high-quality cancer care services to patients throughout central Alabama. 

 

At its state-of-the-art campus in Fresno, Calif., and at several offices in San Diego, Calif., (including a new radiation center opening at the end of 2012), cCARE’s extensive team of board-certified oncologists, hematologists and nurses offer a wide range of innovative cancer and blood disorder services to patients throughout central and southern California. 

 

Michigan Healthcare Professionals, P.C. is a newly formed multi-location physician group practice that includes Oakland Medical Group and Hematology & Oncology Consultants.  This group currently provides care to cancer patients in five locations throughout southeastern Michigan.

 

“VitalSource is excited to provide each of these well-respected oncology groups with the support services they need to continue to run successful, efficient businesses that provide patients with access to quality, local, convenient cancer care,” said Gary Ingold, vice president and general manager of Cardinal Health Specialty Solutions. “We look forward to continuing to provide deep clinical and business expertise to help these new VitalSource members thrive in today’s challenging environment.”

 

These new VitalSource customers will have access to the following services:

 

·         Financial Management Solutions to help practices optimize their businesses by maximizing revenue and improving operational efficiency.  The centerpiece of these solutions is the eobONE® Reimbursement Solution, a proprietary, Web-based practice efficiency platform that improves revenue cycle management and medication reimbursements.

 

Experts from Cardinal Health Specialty Solutions can also review medication-use patterns and recommend more cost-effective therapeutic substitutions that are clinically proven to be of equal or greater efficacy. 

 

·         Time Management Solutions that alleviate the burden of excessive paperwork and pressures practices face every day, by offering resources like ready-to-use clinical support toolkits, a drug shortage resource center and drug information services that save practices both time and money.

 

·         Publications and Education that provide access to the latest and most relevant clinical news, via webcasts and e-newsletters that share expert insight on trends in the community oncology industry. Members also receive monthly portfolio updates, summarizing changes in contracts, drug formulations and pricing.

 

To learn more about VitalSource, or to become a VitalSource member, visit www.VitalSourceGPO.com. 

 

About Cardinal Health Specialty Solutions

Cardinal Health Specialty Solutions provides regulatory, clinical, reimbursement, technology and distribution services to help health care professionals, payors and pharmaceutical and biotech companies improve the quality and cost-effectiveness of caring for patients who are managing complex diseases.  Cardinal Health Specialty Solutions partners with customers to alleviate day-to-day administrative burdens, optimize business functions and to implement new innovations that move their businesses forward.  To learn more, visit www.cardinalhealth.com/specialtysolutions.

 

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $103 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while  reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #21 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com and @CardinalHealth on Twitter.

More Company News
11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

11/05/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on...

11/01/2024

Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating earnings were $568 million; GAAP...

View all company news »